The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
We are a venture capital fund investing in early-stage technology startups with strong ties to Greece. We provide initial investment of €200K – €400K at the pre-seed stage and up to 1.5M at Seed and Seed+ stage, complimented by hands-on support.
Venture capitalmetavallon.vcSince 2026-09-22
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Anacalypsis Therapeutics A startup focused on treatments for LRRK2-associated Parkinson's disease | Pre-seed Developing, 5 sources | n/a | 2026-09-22 | [ LEAD ] |
No one else named on these rounds.